Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

IRON | Disc Medicine Inc

Index	RUT	P/E	-	EPS (ttm)	-3.92	Insider Own	54.70%	Shs Outstand	17.40M	Perf Week	-4.76%
Market Cap	1.11B	Forward P/E	-	EPS next Y	-4.49	Insider Trans	-14.31%	Shs Float	10.36M	Perf Month	-12.47%
Income	-63.23M	PEG	-	EPS next Q	-0.80	Inst Own	41.61%	Short Float / Ratio	4.85% / 2.37	Perf Quarter	-6.85%
Sales	0.00M	P/S	-	EPS this Y	92.22%	Inst Trans	4.43%	Short Interest	0.50M	Perf Half Y	114.39%
Book/sh	16.25	P/B	2.98	EPS next Y	-28.04%	ROA	-25.42%	Target Price	60.89	Perf Year	269.69%
Cash/sh	16.50	P/C	2.93	EPS next 5Y	-	ROE	-26.45%	52W Range	11.80 - 57.70	Perf YTD	143.49%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-16.95%	52W High	-16.07%	Beta	-0.03
Dividend %	-	Quick Ratio	39.42	Sales past 5Y	0.00%	Gross Margin	-	52W Low	310.42%	ATR	2.55
Employees	46	Current Ratio	39.42	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	39.59	Volatility	4.71% 5.12%
Optionable	Yes	Debt/Eq	0.01	EPS Q/Q	54.74%	Profit Margin	-	Rel Volume	0.78	Prev Close	47.64
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 11 BMO	Payout	-	Avg Volume	212.16K	Price	48.43
Recom	1.00	SMA20	-7.59%	SMA50	-4.96%	SMA200	42.22%	Volume	165,416	Change	1.66%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-09-23	Upgrade	Raymond James	Outperform → Strong Buy	$50 → $75
Jun-07-23	Initiated	H.C. Wainwright	Buy	$55
May-17-23	Initiated	Raymond James	Outperform	$50
Apr-28-23	Initiated	Cantor Fitzgerald	Overweight	$45
Apr-21-23	Initiated	Stifel	Buy	$37
Apr-20-23	Initiated	Morgan Stanley	Overweight	$37
Mar-23-23	Initiated	BMO Capital Markets	Outperform	$40
Feb-28-23	Initiated	SVB Securities	Outperform	$36

Sep-20-23 04:30PM	Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera (GlobeNewswire)
Aug-30-23 04:15PM	Disc Medicine to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-24-23 11:20AM	Stock Screen Finds These Growth Stocks Outperforming The S&P 500 (Investor's Business Daily)
Aug-11-23 08:50AM	Recent Price Trend in Disc Medicine, Inc. (IRON) is Your Friend, Here's Why (Zacks)
08:00AM	Disc Medicine Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
09:00AM	Loading…
Jul-27-23 09:00AM	Disc Medicine Announces First Patient Enrolled in Phase 1/2 Clinical Trial of Bitopertin in Diamond-Blackfan Anemia (DBA) (GlobeNewswire)
Jul-25-23 09:55AM	Here's Why Disc Medicine, Inc. (IRON) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Jun-22-23 04:15PM	Disc Medicine Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters Option to Purchase Additional Shares (GlobeNewswire)
Jun-20-23 07:33PM	Load Up, Says Raymond James About These 2 Strong Buy Stocks (TipRanks) +7.20%
Jun-13-23 10:39PM	Disc Medicine Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
Jun-12-23 04:00PM	Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire) +6.92%
01:59AM	4 big analyst picks: Adobe a buy on AI hopes, says Wells Fargo (Investing.com)
Jun-09-23 04:13PM	Why Perfectly Rated Disc Medicine, With A 287% Move This Year, Just Put Up Another Big Gain (Investor's Business Daily) +15.76%
07:00AM	Disc Presents Positive Initial Data from Phase 2 BEACON Trial of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress (GlobeNewswire)
Jun-01-23 03:10PM	Why Shares of Disc Medicine Opco Climbed This Week (Motley Fool) +7.06%
04:00PM	Loading…
May-31-23 04:00PM	Disc Medicine to Participate in the Jefferies Healthcare Conference (GlobeNewswire) +12.01%
May-15-23 07:00AM	Disc Medicine Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-11-23 10:15AM	Disc Medicine Announces Presentation of Initial Data from Phase 2 BEACON Trial in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress (GlobeNewswire)
May-10-23 10:23AM	Is a Surprise Coming for Disc Medicine (IRON) This Earnings Season? (Zacks) +5.24%
May-05-23 08:50AM	Disc Medicine, Inc. (IRON) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
May-04-23 12:00PM	Disc Medicine, Inc. (IRON) Is Up 4.40% in One Week: What You Should Know (Zacks)
Apr-28-23 05:00AM	Zacks.com featured highlights Harrow Health and Disc Medicine Opco (Zacks)
Apr-27-23 08:05AM	2 Stocks in Focus as Analysts Initiate Coverage (Zacks)
Apr-21-23 08:30AM	Disc Medicine to Participate in H.C. Wainwright BioConnect Investor Conference (GlobeNewswire) +11.57%
Apr-19-23 08:50AM	Recent Price Trend in Disc Medicine, Inc. (IRON) is Your Friend, Here's Why (Zacks)
Apr-13-23 11:00AM	Disc Medicine to Host Disease Webinar with KOLs on Erythropoietic Protoporphyria (EPP) (GlobeNewswire)
Mar-31-23 07:00AM	Disc Medicine Reports Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Mar-30-23 07:05AM	Disc Medicine Opco Inc (NASDAQ:IRON) most popular amongst private equity firms who own 48% of the shares, institutions hold 21% (Simply Wall St.)
Mar-21-23 07:00AM	Disc Medicine Announces Collaboration with National Institutes of Health for Phase 2 Clinical Study of Bitopertin in Patients with Diamond-Blackfan Anemia (DBA) (GlobeNewswire)
Feb-16-23 08:00AM	Disc Medicine Initiates a Phase 1b/2 Clinical Study of DISC-0974 in Adults with Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD) and Anemia (GlobeNewswire)
06:30AM	Loading…
Feb-14-23 06:30AM	Disc Medicine Announces $62.5 Million Financing led by Bain Capital Life Sciences to Advance Portfolio of Novel Hematology Programs (GlobeNewswire)
Feb-08-23 04:00PM	Disc Medicine to Participate in SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-20-23 07:00AM	Disc Medicine Announces Exclusive Licensing Agreement with Mabwell Therapeutics for Novel Anti-TMPRSS6 Monoclonal Antibodies to Modulate Iron Homeostasis (GlobeNewswire)

Disc Medicine, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from serious hematologic disorders. The company was founded in October 2017 and is headquartered in Watertown, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Atlas Venture Fund X, L.P.	10% Owner	Sep 16	Sale	53.22	2,115	112,560	1,593,785	Sep 18 04:59 PM
Atlas Venture Fund X, L.P.	10% Owner	Sep 15	Sale	53.16	260,894	13,869,125	1,595,900	Sep 18 04:59 PM
Atlas Venture Fund X, L.P.	10% Owner	Sep 14	Sale	53.05	94,440	5,010,042	1,856,794	Sep 18 04:59 PM
Bryce Joanne	Chief Financial Officer	Sep 11	Option Exercise	9.86	2,500	24,650	3,760	Sep 13 04:15 PM
Bryce Joanne	Chief Financial Officer	Sep 01	Option Exercise	2.65	1,000	2,650	2,260	Sep 05 04:16 PM
Bryce Joanne	Chief Financial Officer	Sep 01	Sale	52.99	1,000	52,990	1,260	Sep 05 04:16 PM
Savage William Jacob	Chief Medical Officer	Aug 21	Option Exercise	2.65	3,000	7,950	3,000	Aug 22 04:06 PM
Atlas Venture Fund X, L.P.	10% Owner	Aug 15	Sale	52.40	111,069	5,820,016	1,951,234	Aug 16 06:55 PM
Bitterman Kevin	Director	Aug 15	Sale	52.40	72,931	3,821,584	882,224	Aug 17 04:13 PM
Atlas Venture Fund X, L.P.	10% Owner	Aug 15	Sale	52.40	72,931	3,821,584	882,224	Aug 16 06:55 PM
Savage William Jacob	Chief Medical Officer	Aug 15	Sale	52.95	7,672	406,235	0	Aug 16 04:15 PM
Atlas Venture Fund X, L.P.	10% Owner	Aug 14	Sale	52.59	175,000	9,203,600	2,062,303	Aug 16 06:55 PM
Savage William Jacob	Chief Medical Officer	Aug 09	Sale	49.83	8,269	412,064	7,672	Aug 11 04:15 PM
Bryce Joanne	Chief Financial Officer	Aug 01	Option Exercise	1.01	4,521	4,566	5,781	Aug 03 04:18 PM
Bryce Joanne	Chief Financial Officer	Aug 01	Sale	49.91	4,521	225,633	1,260	Aug 03 04:18 PM
MacDonald Brian Richard	Chief Innovation Officer	Jun 30	Sale	45.05	4,324	194,778	12,876	Jun 30 06:29 PM
MacDonald Brian Richard	Chief Innovation Officer	Jun 29	Sale	45.79	5,100	233,509	17,200	Jun 30 06:29 PM
Bryce Joanne	Chief Financial Officer	Jun 28	Option Exercise	1.01	7,880	7,959	11,332	Jun 30 04:49 PM
Novo Holdings A/S	10% Owner	Jun 28	Sale	46.10	1,250,000	57,625,000	1,090,772	Jun 28 05:04 PM
Bryce Joanne	Chief Financial Officer	Jun 28	Sale	49.95	10,072	503,114	1,260	Jun 30 04:49 PM
MacDonald Brian Richard	Chief Innovation Officer	Jun 28	Sale	49.96	5,100	254,795	22,300	Jun 30 06:29 PM
Savage William Jacob	Chief Medical Officer	Jun 28	Sale	49.98	4,384	219,114	15,941	Jun 30 04:12 PM
AI DMI LLC	10% Owner	Feb 15	Buy	23.00	434,783	10,000,009	3,141,759	Feb 17 04:42 PM
Ashiya Mona	Director	Feb 15	Buy	23.00	108,696	2,500,008	1,196,825	Feb 17 04:48 PM
ORBIMED ADVISORS LLC	Director	Feb 15	Buy	23.00	108,696	2,500,008	1,196,825	Feb 17 04:43 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IRON | Disc Medicine Inc

Upgrade your FINVIZ experience